These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7561186)

  • 1. Quantitative relationship of circulating p24 antigen with human immunodeficiency virus (HIV) RNA and specific antibody in HIV-infected subjects receiving antiretroviral therapy. The RV43 Study Group.
    Brown AE; Vahey MT; Zhou SY; Chung RC; Ruiz NM; Hofheinz D; Lane JR; Mayers DL
    J Infect Dis; 1995 Oct; 172(4):1091-5. PubMed ID: 7561186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J
    AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
    Kappes JC; Saag MS; Shaw GM; Hahn BH; Chopra P; Chen S; Emini EA; McFarland R; Yang LC; Piatak M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):139-49. PubMed ID: 7552477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
    Bonard D; Rouet F; Toni TA; Minga A; Huet C; Ekouévi DK; Dabis F; Salamon R; Rouzioux C;
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):267-73. PubMed ID: 14600570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patients.
    Fenouillet E; Blanes N; Coutellier A; Gluckman JC
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1251-5. PubMed ID: 8142142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous in vitro anti-human immunodeficiency virus type 1 antibody secretion by peripheral blood mononuclear cells is related to disease progression in zidovudine-treated adults.
    Conge AM; Reynes J; Atoui N; Huguet MF; Ducos J; Bonardet A; Serre A; Vendrell JP
    J Infect Dis; 1994 Dec; 170(6):1376-83. PubMed ID: 7995975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection.
    Relimpio F; Rey C; Pineda JA; Leal M; Caruz A; Sánchez-Quijano A; Lissen E
    Antivir Ther; 1997 Apr; 2(2):99-104. PubMed ID: 11322281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantification of the levels of p24 antigen and antibodies in human immunodeficiency virus infection].
    García F; Quirós E; Bernal MC; Alados JC; González MI; Maroto MC
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):75-8. PubMed ID: 1643142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
    Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
    JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Read JS; Rich KC; Korelitz JJ; Mofenson LM; Harris R; Moye JH; Meyer WA; Pahwa SG; Bethel JW; Nugent RP
    Pediatr Infect Dis J; 2000 Jun; 19(6):544-51. PubMed ID: 10877171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
    Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
    Fiscus SA; Hughes MD; Lathey JL; Pi T; Jackson B; Rasheed S; Elbeik T; Reichman R; Japour A; Byington R; Scott W; Griffith BP; Katzenstein DA; Hammer SM
    J Infect Dis; 1998 Mar; 177(3):625-33. PubMed ID: 9498441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and immunological correlates of immune-complex-dissociated HIV-1 p24 antigen in HIV-1-infected children.
    Duiculescu DC; Geffin RB; Scott GB; Scott WA
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):807-15. PubMed ID: 7912730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
    Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR; Weinstein RA; Whaling SM; Ou CY; Connolly PJ; Moore JL; Bitran JD
    J Infect Dis; 1992 May; 165(5):793-8. PubMed ID: 1349031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy.
    Semple M; Loveday C; Weller I; Tedder R
    J Med Virol; 1991 Sep; 35(1):38-45. PubMed ID: 1940882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 (HIV-1) viremia changes and development of drug-related mutations in patients with symptomatic HIV-1 infection receiving alternating or simultaneous zidovudine and didanosine therapy.
    Kojima E; Shirasaka T; Anderson BD; Chokekijchai S; Steinberg SM; Broder S; Yarchoan R; Mitsuya H
    J Infect Dis; 1995 May; 171(5):1152-8. PubMed ID: 7751690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.